Scandion Oncology A/S (STO:SCOL)

Scandion Oncology Balance Sheet

Financials in millions DKK. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	12.69	26.52	77.61	105.71	5.81
Cash & Short-Term Investments	12.69	26.52	77.61	105.71	5.81
Cash Growth	-52.17%	-65.83%	-26.59%	1718.20%	-62.30%
Other Receivables	5.06	6.53	8.52	7.52	5.8
Receivables	5.06	6.53	8.52	7.52	5.8
Prepaid Expenses	0.4	0.61	0.73	1.08	0.2
Other Current Assets	0	-	-	-	174.32
Total Current Assets	18.14	33.66	86.86	114.3	186.13
Property, Plant & Equipment	0.07	0.65	2.26	1.6	0.45
Other Long-Term Assets	0.07	0.25	0.29	0.31	0.15
Total Assets	18.28	34.56	89.4	116.22	186.72
Accounts Payable	1.65	1.38	4.9	4.58	26.06
Current Portion of Leases	0.07	0.5	0.78	0.72	0.32
Other Current Liabilities	8.29	1.56	12.58	5.79	3.96
Total Current Liabilities	10.01	3.44	18.25	11.09	30.34
Long-Term Leases	-	-	0.82	0.5	-
Long-Term Deferred Tax Liabilities	-	-	-	-	0.01
Other Long-Term Liabilities	-	-	-0	0.08	0.5
Total Liabilities	10.01	3.44	19.07	11.68	30.85
Common Stock	17.26	2.99	2.99	2.36	2.36
Additional Paid-In Capital	232.55	233.01	233.01	191.15	191.15
Retained Earnings	-241.54	-204.88	-165.67	-88.97	-37.65
Shareholders' Equity	8.27	31.12	70.33	104.54	155.87
Total Liabilities & Equity	18.28	34.56	89.4	116.22	186.72
Total Debt	0.07	0.5	1.6	1.22	0.32
Net Cash (Debt)	12.62	26.02	76.01	104.49	5.5
Net Cash Growth	-51.51%	-65.77%	-27.26%	1800.45%	-64.34%
Net Cash Per Share	0.05	0.64	1.87	3.25	0.28
Filing Date Shares Outstanding	234.76	40.71	40.71	32.14	32.14
Total Common Shares Outstanding	234.76	40.71	40.71	32.14	32.14
Working Capital	8.13	30.23	68.6	103.21	155.78
Book Value Per Share	0.04	0.76	1.73	3.25	4.85
Tangible Book Value	8.27	31.12	70.33	104.54	155.87
Tangible Book Value Per Share	0.04	0.76	1.73	3.25	4.85
Machinery	0.16	0.26	0.91	0.5	0.18

Updated Mar 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.